Solid presentation. OTC products are going to have issues especially after reading that article yesterday. Also competitor drugs should be worried about market share being taken with a much better safety profile of BTX 1503.BOT leading the way with clinical data that is proven.
Ann: Botanix Presents at International Cannabinoid Summit, page-9
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.020(4.82%) |
Mkt cap ! $789.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.0¢ | 41.5¢ | $3.690M | 8.569M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66897 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 414256 | 15 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |